BBG Advanced Therapies provides a wide range of research grade and cGMP starting materials for further manufacture into Advanced Therapies.
The organization has expertise in providing customized solutions for donor qualification (demographics, infectious disease testing, medical social history), collection procedures, documentation, and post-collection processing in accordance with 21 CFR 1271.
Services and collections can be customized to meet the unique project needs of therapeutic developers.
cGMP starting materials for further manufacturing and research are collected in accordance with 21 CFR 1271 at our collection facilities. All living donors are collected under IRB-approved protocols and research informed consent. Donor screening is compliant with FDA and international regulatory requirements.
*FACT-accredited for peripheral blood cellular therapy product collection.
